En vivo

Lonza NewsLonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma Post Eli LillyGilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN Thermo FisherThe Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo Finance Bio-Gene Technology LtdBio-Gene lifts placement size with additional shares and options - TipRanks 10x Genomics BlogThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - AOL.com Eli LillyGilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - Stocktwits PfizerPfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord Pharma Endpoints NewsOtsuka touts new IgAN evidence as it seeks full approval for Voyxact AgilentA Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st Boston ScientificBoston Scientific to open $138M medical device distribution facility in Indiana, adding 300 jobs - MassDevice Charles RiverCharles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWS Endpoints NewsActing FDA chief isn't interested in permanent role

Cell 28 mar 2026

Whole-body molecular and cellular mapping of the laboratory mouse

Publication date: 28 May 2026 Source: Cell, Volume 189, Issue 11 Author(s): Margarette H. Clevenger, Denis Cipurko, Ashwini Patil, Bohan Li, Michihiro Takahama,...

Publication date: 28 May 2026 Source: Cell, Volume 189, Issue 11 Author(s): Margarette H. Clevenger, Denis Cipurko, Ashwini Patil, Bohan Li, Michihiro Takahama, Linghan Mei, Madison Plaster, Gabriella Richey, Tadafumi Kawamoto, Feng Bao, Nicolas Chevrier